As of July 22, 2007 the name of the Association of Glaucoma Societies
has been changed into WORLD GLAUCOMA ASSOCIATION
has been changed into WORLD GLAUCOMA ASSOCIATION
news
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
GLAUCOMA PATIENTS
ASSOCIATION (SINGAPORE)
ASSOCIATION (SINGAPORE)
4/19/07 -Gelatine-based nanoparticles may offer a new delivery
route for gene therapy that skirts the complications of viral-based
vectors.
route for gene therapy that skirts the complications of viral-based
vectors.
4/4/2007 - Pfizer has homed in pSivida's controlled release drug
delivery technology, signing a research and licensing deal worth $165m
(€123.5m) and focusing keenly on the company's Medidur technology
for new ophthalmic applications.
delivery technology, signing a research and licensing deal worth $165m
(€123.5m) and focusing keenly on the company's Medidur technology
for new ophthalmic applications.
07/08/2007 - UK researchers have published results linking the beta
amyloid protein associated with Alzheimer's disease to glaucoma,
opening up a much needed new target for glaucoma therapies.
amyloid protein associated with Alzheimer's disease to glaucoma,
opening up a much needed new target for glaucoma therapies.
8/21/2007 - US researchers have developed a nanogel drug delivery
system which has the potential for controlled release activity and
targeted drug delivery.
system which has the potential for controlled release activity and
targeted drug delivery.
BREAKING NEWS!
On Aug 30, 2007 the GLAUCOMA PATIENTS ASSOCIATION
(SINGAPORE) was formally approved by the Registrar of Societies
under the Societies Act
(SINGAPORE) was formally approved by the Registrar of Societies
under the Societies Act
08/29/2007 - Sangamo Biosciences is engineering synthetic versions
of the body's natural DNA regulators for a variety of therapeutic
purposes, including against cancer, HIV/AIDS and diabetic
neuropathy.
of the body's natural DNA regulators for a variety of therapeutic
purposes, including against cancer, HIV/AIDS and diabetic
neuropathy.
8/31/2007 IOP increase after pupil dilatation may indicate future
glaucoma progression
glaucoma progression
07/20/2007 WGA Announces Consensus Findings To Further
Define The Role Of Intraocular Pressure In Glaucoma
Define The Role Of Intraocular Pressure In Glaucoma
07/19/2007 Global panel issues consensus on role of IOP in glaucoma
10/02/2007 - TheraKine and Capsulution NanoScience are
collaborating to develop new drug delivery systems to aid in the
treatment of serious eye diseases.
collaborating to develop new drug delivery systems to aid in the
treatment of serious eye diseases.
Reducing IOP with fixed-combination regimen
by Anastasios G.P. Konstas, MD, PhD
by Anastasios G.P. Konstas, MD, PhD